Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease

This study has been terminated.
National Taiwan University Hospital
Information provided by:
Nang Kuang Pharmaceutical Co., Ltd. Identifier:
First received: April 21, 2010
Last updated: June 7, 2011
Last verified: June 2011
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2011
  Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)